Corrigendum: Low-molecular-weight heparin versus aspirin in early management of acute ischemic stroke: A systematic review and meta-analysis

Hui Xia,Ziyao Wang,Min Tian,Zunjing Liu,Zhenhua Zhou

DOI: https://doi.org/10.3389/fimmu.2022.1052766

IF: 7.3

2022-11-10

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.823391.].

immunology

What problem does this paper attempt to address?

Correction: Aliskiren Therapy in Hypertension and Cardiovascular Disease: a Systematic Review and a Meta-Analysis

Shufang Fu,Xin Wen,Fei Han,Longwei Yin,Gaosi Xu

DOI: https://doi.org/10.18632/oncotarget.24255

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.19382.].
Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Hangying Ying,Hongdi Yuan,Xiaomei Tang,Wenpu Guo,Ruhong Jiang,Chenyang Jiang

DOI: https://doi.org/10.3389/fcvm.2021.723626

IF: 3.6

2021-01-01

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.641062.].
Low-Molecular-Weight Heparin Versus Aspirin in Early Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

Hui Xia,Ziyao Wang,Min Tian,Zunjing Liu,Zhenhua Zhou

DOI: https://doi.org/10.3389/fimmu.2022.823391

IF: 7.3

2022-02-24

Frontiers in Immunology

Abstract:Objectives To evaluate the difference between low-molecular-weight heparin (LMWH) and aspirin in preventing early neurological deterioration (END) and recurrent ischemic stroke (RIS), post-recovery independence, and safety outcomes in acute ischemic stroke. Materials and Methods We performed systematic searches of the PubMed, Embase, Web of Science, and Cochrane Library databases for full-text articles of randomized controlled trials (RCTs) of LMWH vs. aspirin in the early management of acute ischemic stroke. Information on study design, eligibility criteria, baseline information, and outcomes was extracted. Synthesized relative risks (RRs) with 95% confidence intervals (CIs) are used to present the differences between the two treatments based on fixed-effects models. Results Five RCTs were retrieved from the online databases. The results showed no significant difference in efficacy outcomes between the two groups among unselected patients. Subgroup analysis showed that LMWH was significantly related to a lower incidence of END events [relative risk (RR): 0.44, 95% confidence interval (CI): 0.35–0.56] and reduced occurrence of RIS during treatment (OR: 0.34, 95% CI: 0.16–0.75) in non-cardioembolic stroke. LMWH significantly increased the number of patients with a modified Rankin scale (mRS) score of 0–1 at 6 months in patients with large-artery occlusive disease (LAOD) (RR: 0.50, 95% CI: 0.27–0.91). LMWH had a similar effect on symptomatic intracranial hemorrhage (sICH) and major extracranial hemorrhage during treatment to that of aspirin, except that LMWH was related to an increased likelihood of extracranial hemorrhage. Conclusions In patients with acute non-cardioembolic ischemic stroke, especially that with large-artery stenosis, LMWH treatment significantly reduced the incidence of END and RIS, and improved the likelihood of independence (mRS 0–1) at 6 months compared with those with aspirin treatment. LMWH was related to an increased likelihood of extracranial hemorrhage among all patients; however, the difference in major extracranial hemorrhage and sICH was not significant. Choosing the appropriate patients and paying attention to the start time and duration of treatment are very important in the use of anticoagulation. Systematic Review Registration http://www.crd.york.ac.uk/PROSPERO , identifier CRD42020185446.

immunology
Corrigendum: Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke

Tingting Liu,Yanan Li,Xiaoyuan Niu,Yongle Wang,Kaili Zhang,Haimei Fan,Jing Ren,Juan Li,Yalan Fang,Xinyi Li,Xuemei Wu

DOI: https://doi.org/10.3389/fneur.2022.1053112

IF: 3.4

2022-10-14

Frontiers in Neurology

Abstract:[This corrects the article DOI: 10.3389/fneur.2022.937417.].

neurosciences,clinical neurology
Corrigendum: The immunomodulatory mechanism of acupuncture treatment for ischemic stroke: research progress, prospects, and future direction

Hongjun Kuang,Xinzhou Zhu,Huan Chen,Han Tang,Hong Zhao

DOI: https://doi.org/10.3389/fimmu.2024.1468179

2024-08-16

Abstract:[This corrects the article DOI: 10.3389/fimmu.2024.1319863.].
Corrigendum to "endovascular Treatment of Acute Basilar Artery Occlusion Caused by Vertebral Artery Stump Syndrome: A Clinical Analysis of 37 Cases" [heliyon 9 (4X), (march 2023) Article E14956].

Keqi Lei,Weiping Chen,Zhijuan Cheng,Fang Li,Kai Wang,Min Yin,Xingen Zhu,Hua Guo,Jianglong Tu

DOI: https://doi.org/10.1016/j.heliyon.2023.e17455

IF: 3.776

2023-01-01

Heliyon

Abstract:[This corrects the article DOI: 10.1016/j.heliyon.2023.e14956.].
Corrigendum: Systematic review and meta-analysis of the efficacy and safety of electroacupuncture for poststroke dysphagia

Xuezheng Li,Lijun Lu,Xuefeng Fu,Hao Li,Wen Yang,Hua Guo,Kaifeng Guo,Zhen Huang

DOI: https://doi.org/10.3389/fneur.2023.1359704

IF: 3.4

2024-01-10

Frontiers in Neurology

Abstract:[This corrects the article DOI: 10.3389/fneur.2023.1270624.].

neurosciences,clinical neurology
Corrigendum: Association Between D-dimer and Early Adverse Events in Patients with Acute Type A Aortic Dissection Undergoing Arch Replacement and the Frozen Elephant Trunk Implantation: A Retrospective Cohort Study

Tong Liu,Jun Zheng,You-Cong Zhang,Kai Zhu,Hui‐Qiang Gao,Kai Zhang,Xiu-Feng Jin,Shang-Dong Xu

DOI: https://doi.org/10.3389/fphys.2020.00409

IF: 4

2020-01-01

Frontiers in Physiology

Abstract:[This corrects the article DOI: 10.3389/fphys.2019.01627.].
Corrigendum: Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis

Yu-Yang Liu,Yi-Yang Qu,Shang Wang,Ci-Jun Luo,Hong-Ling Qiu,Hui-Ting Li,Ping Yuan,Lan Wang,Jin-Ling Li,Rong Jiang,Rui Zhang

DOI: https://doi.org/10.3389/fphar.2023.1155631

IF: 5.6

2023-02-20

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2023.1052546.].

pharmacology & pharmacy
Corrigendum: Systematic review and meta-analysis of Coptis Chinensis Franch. -containing traditional Chinese medicine as an adjunct therapy to metformin in the treatment of type 2 diabetes mellitus

Linlin Pan,Xin Zhai,Zhanhui Duan,Kun Xu,Guirong Liu

DOI: https://doi.org/10.3389/fphar.2022.1112418

IF: 5.6

2023-01-04

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.956313.].

pharmacology & pharmacy
Corrigendum: The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years

Chan Wu,Binghong Liu,Ruiying Wang,Gang Li

DOI: https://doi.org/10.3389/fcvm.2022.900621

2022-05-12

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.809580.].
Corrigendum to "Atrase A, a P-III class metalloproteinase purified from cobra venom, exhibits potent anticoagulant activity by inhibiting coagulation pathway and activating the fibrinolytic system" [Heliyon Volume 10, Issue 10, 30 May 2024, Article e30969]

Xin-Jie Zhong,Cai-E Wang,Ya-Nan Li,Qi-Yun Zhang,Qian-Yun Sun

DOI: https://doi.org/10.1016/j.heliyon.2024.e33331

IF: 3.776

2024-06-27

Heliyon

Abstract:[This corrects the article DOI: 10.1016/j.heliyon.2024.e30969.].
Correction: Technology-Based Interventions in Oral Anticoagulation Management: Meta-Analysis of Randomized Controlled Trials

Hengfen Dai,Caiyun Zheng,Chun Lin,Yan Zhang,Hong Zhang,Fan Chen,Yunchun Liu,Jingwen Xiao,Chaoxin Chen

DOI: https://doi.org/10.2196/22761

IF: 7.076

2020-08-04

Journal of Medical Internet Research

Abstract:[This corrects the article DOI: 10.2196/18386.].

health care sciences & services,medical informatics
Corrigendum to “Safety and efficacy of ablation index-guided high-power ablation for the treatment of atrial fibrillation” [Heliyon 9 (4), (April 2023) Article e15311]

Jing Zhu,Xian-he Lin

DOI: https://doi.org/10.1016/j.heliyon.2023.e17578

IF: 3.776

2023-06-01

Heliyon

Abstract:[This corrects the article DOI: 10.1016/j.heliyon.2023.e15311.].
Corrigendum: Network pharmacology and experimental study of phenolic acids in salvia miltiorrhiza bung in preventing ischemic stroke

Chengdi Liu,Lida Du,Sen Zhang,Haigang Wang,Linglei Kong,Guanhua Du

DOI: https://doi.org/10.3389/fphar.2023.1155574

IF: 5.6

2023-02-13

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2023.1108518.].

pharmacology & pharmacy
Corrigendum: Improvement of Sepsis Prognosis by Ulinastatin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Huifang Wang,Bin Liu,Ying Tang,Ping Chang,Lishuai Yao,Bo Huang,Robert F Lodato,Zhanguo Liu

DOI: https://doi.org/10.3389/fphar.2019.01697

2020-02-21

Abstract:[This corrects the article DOI: 10.3389/fphar.2019.01370.].
Corrigendum: Early-Onset Depression in Stroke Patients: Effects on Unfavorable Outcome 5 Years Post-stroke

Ya-Ying Zeng,Meng-Xuan Wu,Sheng-Nan Zhou,Dan-Dan Geng,Lin Cheng,Kai-Li Fan,Xin Yu,Wen-Jie Tang,Jin-Cai He

DOI: https://doi.org/10.3389/fpsyt.2021.732437

IF: 4.7

2021-07-29

Frontiers in Psychiatry

Abstract:[This corrects the article DOI: 10.3389/fpsyt.2021.556981.].

psychiatry
Corrigendum: A machine learning model for visualization and dynamic clinical prediction of stroke recurrence in acute ischemic stroke patients: a real-world retrospective study

Kai Wang,Qianqian Shi,Chao Sun,Wencai Liu,Vicky Yau,Chan Xu,Haiyan Liu,Chenyu Sun,Chengliang Yin,Xiu'e Wei,Wenle Li,Liangqun Rong

DOI: https://doi.org/10.3389/fnins.2023.1235340

IF: 4.3

2023-07-10

Frontiers in Neuroscience

Abstract:[This corrects the article DOI: 10.3389/fnins.2023.1130831.].

neurosciences
Clinical Efficacy of the Huo Xue Hua Yu Method Combined with Aspirin in the Treatment of Acute Cerebral Infarction: A systematic evaluation and Meta-Analysis

Chu Chen,Fang Ma,Xinli Wen,Xing Liu,Qing Tang,yilun Wu

DOI: https://doi.org/10.2174/1381612829666230622110753

IF: 3.31

2023-06-22

Current Pharmaceutical Design

Abstract:Objective: The study aimed to evaluate the clinical efficacy of the Huo Xue Hua Yu method combined with aspirin in the treatment of patients with acute cerebral infarction (ACI). Methods: By searching electronic databases, such as the Chinese Biomedical Literature Database (CBM), the China National Knowledge Infrastructure Database (CNKI), the China Science and Technology Journal Database, Wanfang, PubMed, Embase, and the Cochrane Library, all randomized controlled trials (RCTs) published before 14 July, 2022, and published in Chinese or English languages were selected. Statistical analysis was performed using Review Manager 5.4 calculation software to calculate the odds ratio (OR), mean difference (MD), 95% confidence interval (CI), and p values. Results: 13 articles that included 1,243 patients were identified; in 646 of them, the Huo Xue Hua Yu method combined with aspirin has been administered, while 597 have only been administered aspirin therapy. The combined treatment significantly improved clinical efficacy (OR: 4.41, 95% CI: 2.90 to 5.84, P < 0.001, I2 = 0), as assessed by the National Institutes of Health Stroke Scale score (MD= -4.18, 95% CI: -5.69 to -2.67, P < 0.001, I2 = 94%), Barthel score (MD = -2.23, 95% CI: -2.66 to -1.81, P < 0.001, I2 = 82%), the China Stroke Scale score (MD = 6.74, 95% CI: -3.49 to 16.96, P = 0.20, I2 = 99%), packed cell volume (MD = -8.45, 95% CI: -8.81 to -8.09, P < 0.001, I2 = 98%), fibrinogen levels (MD = -0.93, 95% CI: -1.23 to -0.63, P < 0.001, I2 = 78%) and plasma viscosity (MD = -0.51, 95% CI: -0.72 to -0.30, P < 0.001, I2 = 62%). Conclusion: The combination of the Huo Xue Hua Yu method and aspirin represents a beneficial adjunctive therapy for ACI.

pharmacology & pharmacy
Corrigendum: Selective intraarterial hypothermia combined with mechanical thrombectomy for acute cerebral infarction based on microcatheter technology: a single-center, randomized, single-blind controlled study

Yue Wan,Hao Tian,Hui Wang,DaPeng Wang,HaiWei Jiang,Qi Fang

DOI: https://doi.org/10.3389/fneur.2024.1498742

IF: 3.4

2024-10-10

Frontiers in Neurology

Abstract:This article is a correction to: Selective intraarterial hypothermia combined with mechanical thrombectomy for acute cerebral infarction based on microcatheter technology: A single-center, randomized, single-blind controlled study

neurosciences,clinical neurology

Corrigendum: Low-molecular-weight heparin versus aspirin in early management of acute ischemic stroke: A systematic review and meta-analysis

Correction: Aliskiren Therapy in Hypertension and Cardiovascular Disease: a Systematic Review and a Meta-Analysis

Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Low-Molecular-Weight Heparin Versus Aspirin in Early Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

Corrigendum: Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke

Corrigendum: The immunomodulatory mechanism of acupuncture treatment for ischemic stroke: research progress, prospects, and future direction

Corrigendum to "endovascular Treatment of Acute Basilar Artery Occlusion Caused by Vertebral Artery Stump Syndrome: A Clinical Analysis of 37 Cases" [heliyon 9 (4X), (march 2023) Article E14956].

Corrigendum: Systematic review and meta-analysis of the efficacy and safety of electroacupuncture for poststroke dysphagia

Corrigendum: Association Between D-dimer and Early Adverse Events in Patients with Acute Type A Aortic Dissection Undergoing Arch Replacement and the Frozen Elephant Trunk Implantation: A Retrospective Cohort Study

Corrigendum: Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis

Corrigendum: Systematic review and meta-analysis of Coptis Chinensis Franch. -containing traditional Chinese medicine as an adjunct therapy to metformin in the treatment of type 2 diabetes mellitus

Corrigendum: The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years

Corrigendum to "Atrase A, a P-III class metalloproteinase purified from cobra venom, exhibits potent anticoagulant activity by inhibiting coagulation pathway and activating the fibrinolytic system" [Heliyon Volume 10, Issue 10, 30 May 2024, Article e30969]

Correction: Technology-Based Interventions in Oral Anticoagulation Management: Meta-Analysis of Randomized Controlled Trials

Corrigendum to “Safety and efficacy of ablation index-guided high-power ablation for the treatment of atrial fibrillation” [Heliyon 9 (4), (April 2023) Article e15311]

Corrigendum: Network pharmacology and experimental study of phenolic acids in salvia miltiorrhiza bung in preventing ischemic stroke

Corrigendum: Improvement of Sepsis Prognosis by Ulinastatin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Corrigendum: Early-Onset Depression in Stroke Patients: Effects on Unfavorable Outcome 5 Years Post-stroke

Corrigendum: A machine learning model for visualization and dynamic clinical prediction of stroke recurrence in acute ischemic stroke patients: a real-world retrospective study

Clinical Efficacy of the Huo Xue Hua Yu Method Combined with Aspirin in the Treatment of Acute Cerebral Infarction: A systematic evaluation and Meta-Analysis

Corrigendum: Selective intraarterial hypothermia combined with mechanical thrombectomy for acute cerebral infarction based on microcatheter technology: a single-center, randomized, single-blind controlled study